About Us

Pronunciation: Tah·LOW·kin
Thalocan Research Innovations was created to address challenges in clinical trial endpoint management in the immuno-dermatology therapeutic area. With deep experience supporting clinical trial communications and best practices gathered over 18 years, TRI has a focus on process improvement around disease state and endpoint assessment instruction for clinical studies.

ERIC ZUDAK, FOUNDER and CEO
Eric has been working with clinical research teams since 2005, primarily focused on process engineering and technology for the education of Investigators and CRAs. During his time with Trifecta Clinical Eric worked across many therapeutic areas, leading the commercial implementation of enterprise solutions as the Account Director to a fortune 500 Pharma Sponsor. Eric also led client assessment and education programs for many of Trifecta’s portfolio customers, and implementation programs for a large device company as well as several small Biotech’s and CROs. In 2012 Eric led the OUS expansion, opening Trifecta’s first EU based sponsor account and later the first Asia PAC account in Japan.

After Trifecta was acquired by WCG, Eric was asked to serve as co-chair on the WCG Diversity, Equity and Inclusion Council, which he did proudly for 18 months until his departure. Eric counts the opportunity to learn from the DE&I community among the most significant of his career.

Since 2016, his work has been focused on projects related to endpoint assessments for clinical studies in the immuno-dermatology therapeutic area. Working with Sponsors, CROs and Medical Societies, Eric has supported a variety of endpoint measurement and validation projects. These projects include scale and instruction for Atopic Dermatitis, Generalized Pustular Psoriasis, Hand and Foot Syndrome, Hand Eczema, as well as adapting existing scales for used in assessing severity in skin of color.

In founding Thalocan, Eric hopes to improve the disease severity tools, processes, and data in the study of inflammatory skin disease for all stakeholders. The goal is to drive improved metrics for Sponsors, reduce the burden on trial investigators, and maximize the contribution of clinical trial volunteers.

Eric is a graduate of The University of Evansville school of Fine Arts.

CYRUS MIRAKHOR, COO

Take 12 years working in VP and Director level positions for California based startups with a specialty in remote collaboration and learning management. Add another 10 years working in telemedicine support at the National Institutes of Health for large scale imaging, web collaboration, and streaming media deployments. Then, put in a dash of filmmaking with a plethora of award-winning shorts and a feature film and what do you have? 

Someone who thinks it’s time to help revolutionize the way clinical trial efficacy assessment training is captured and delivered, that’s who!

After years working for startups in providing remote collaboration via private managed cloud deployments to Fortune 500 and Federal Government customers, followed by a little bit of AI work as it pertained to Amazon Alexa, Cyrus Mirakhor is happy to be back supporting those with medical research missions.

It was during his tenure in telemedicine as a Collaborations Architect for SAIC at the HHS/NIH that Cyrus found his work most meaningful. His past work includes managing one of the world’s first film-to-digital PACS/DICOM radiology department conversions, taking one of the federal government’s largest streaming media services Videocast.nih.gov from pilot to production, and deploying real time video and web collaboration services throughout the Federal Civilian and Military sectors.

He is honored to join Eric and the fabulous Thalocan team to support your clinical trial success! 

PAUL STROILI, CO-FOUNDER and CREATIVE DIRECTOR
Paul began a career as a designer and creative consultant for Breakdown Services, Ltd, a company at the forefront of creating essential, industry-specific software and solutions to improve the audition and casting process for film, television and live theatre.  He founded Touchstone Graphic Design in 2010 and expanded to include marketing consultation as well as to provide services to clients outside of the entertainment industry.

Since then he has provided creative, design or consultation services to hundreds of clients, including Bally’s Las Vegas, Jim Beam Brands, California Charter School Association, Chevrolet, St. Paul’s Cathedral (San Diego), A World Fit for Kids, The Blume Group, Casting Society of America, Forever Living Products, Glavin Security Specialists, The TNS Group, Fort Raphael Publishing, Youthspeak Collective and Jeff Daniels’ Purple Rose Theatre in Chelsea, Michigan, where he is an artist-in-residence.

Paul attended the State University of New York at New Paltz and while a Los Angeles resident taught Fundamentals of Acting in the UCLA Extension program.  He is a actor, director and playwright (www.paulstroili.com) and his writing has also appeared in Los Angeles Magazine and the Chicago Tribune.

He is proud to assist in providing quality tools, support and trainings to improve the study and assessment of inflammatory skin diseases.

TERESA DEHAEMER, SENIOR DIRECTOR OF BUSINESS STRATEGY

Teresa’s twenty year career within the clinical research realm began following completion of a M.S. in Clinical Psychology. Her first role was actively supporting a depression research study which turned into many years as a clinical research coordinator and site manager for a network of clinical research sites.

To date, she has worked within clinics, two large medical institutions, and a stand-alone research center which were formative to her understanding of the many varied activities and solutions required to drive clinical trials forward. These experiences further influenced her patient centered focus and continues to inspire her dedication to connecting the right solutions for clinical trial participants, clinical sites and sponsors, alike.

Later in her career, she became more involved within the business end of an active research site and pharmaceutical consulting group focused on supporting sponsors in achieving drug approval. This led to many years serving industry within consultative business development roles for CROs, patient recruitment providers, SaaS providers including investigator training, rater training and safety technology solutions, as well as a global decentralized trial provider.

She is honored to rejoin her previous colleague, Eric Zudak, to focus on the disease severity tools, scale development and validation, clinical outcome measurements and other outstanding solutions within dermatology as part of Thalocan Research Innovations’ amazing team.

TYLER WHITE, SENIOR DIRECTOR OF BUSINESS DEVELOPMENT

Tyler is a top-performing, highly motivated sales and operations executive with over 20 years of experience in selling SaaS, both as an individual contributor and a player/coach sales leader. Focused on business development, Tyler excels in implementing effective sales strategies that not only exceed targets but also expand the customer base and deliver sustainable, profitable revenue.

As a results-driven, dynamic, and customer-oriented individual, Tyler has a proven track record of leading business expansion and offering valuable insights into growing business operations. Known for being energetic, persuasive, competitive, and skilled at defining, negotiating, and closing critical business relationships, Tyler strengthens market positions, boosts sales, and supports financial growth.

What Tyler takes the most pride in is the ability to inspire teams to think creatively, motivating multi-unit staff to achieve and surpass goals. A true change agent, Tyler embraces a continuous improvement mindset and fosters a business perspective that promotes collaboration, driving loyalty and results-oriented actions from both team members and business partners alike.

Tyler is thrilled to be part of the Tholocan rocketship and looks forward to supporting the mission of empowering researchers to optimize trial outcomes and streamline operations.

REGAN WANN, SENIOR OPERATIONS CONSULTANT
Regan’s descant of enthusiastic engagement in people arts combined with her love of conscientious methodology brings unique visionary skills to the Thalocan team.  Honed by her years of leadership in higher education, workforce development, public speaking, and training facilitation – with a dash of heart-centered management – these skills help her build out true and collaborative storytelling processes, employing multi-modal, data-informed pedagogical approaches.

Her formative framework being theatre and English literature, Regan has appeared on varied storytelling stages and podcasts, including Risk and The Moth, as well as producing her own events.  Additionally, she coaches and facilitates workshops on interpersonal connection, finding your voice, and authenticity.  She rejuvenates with time spent laughing, exploring improvisational movement, and in the woods or the water.

She is delighted to be joining Thalocan and looks forward to working with you to create dynamic solutions for your clinical study and training needs.

HUNTER STONE, DIRECTOR OF BRAND MARKETING

With over a decade of expertise in marketing and brand development, Hunter Stone is a results-oriented Director of Brand Marketing renowned for crafting high-impact campaigns that not only elevate brand presence but also drive profitability and sustainable growth. With a distinguished background in the luxury hospitality sector, Hunter has a proven track record of transforming brand positioning, optimizing lead generation, driving content creation, and fostering unparalleled customer engagement, all while expertly navigating complex transitions and mergers.

Notably, Hunter played a pivotal role in the seamless marketing transition of an independent luxury brand to its successful integration as a prestigious member of the Marriott Autograph Collection. This complex merger required a keen understanding of brand integrity, strategic positioning, and the ability to maintain the brand’s unique identity while aligning with a global powerhouse.

At Thalocan Research Innovations, we are excited for Hunter to leverage his expertise to propel market growth and solidify Thalocan’s position as an industry leader, driving innovation and shaping its future as a trailblazer in its field.

home_2